MAQUET Medical Systems USA Launches the MIRA-i CS Retractor System for Use During Minimally Invasive Revascularization Procedures
Published: Mar 26, 2013
WAYNE, N.J., March 26, 2013 /PRNewswire/ -- MAQUET Medical Systems USA and MAQUET Cardiovascular today announced the launch of the MIRA-i CS Retractor System, an innovative, modular system designed to provide unsurpassed cardiothoracic access during minimally invasive revascularization procedures. The MIRA-i CS Retractor features a unique, pivoting mechanism that maximizes access and visibility through the smallest of incisions, thus avoiding the need for a sternotomy with its associated risks and complications.
"The MIRA-i CS Retractor is an important addition to our cardiac surgery offering that may allow physicians to improve their practice and help patients quickly return to their normal daily routine," said Raoul Quintero, president and chief executive officer of MAQUET Medical Systems USA. "The use of the MIRA-i CS Retractor during revascularization procedures may reduce post-operative discomfort and lead to a shorter recovery process, faster healing, fewer infections and less scarring for patients."
The MIRA-i CS Retractor offers both titanium internal mammary artery (IMA) blades, which attach to any table-based retractor system providing lift for easy access to this artery, as well as aluminum thoracotomy bladesall of which are radiolucent, making them compatible with diagnostic imaging during hybrid PCI-CABG procedures. The MIRA-i CS Retractor unique pivot mechanism allows the blades to deflect up to 30 degrees, increasing visibility and instrument maneuverability, without the need to increase the incision length. Furthermore, the interchangeable blades attach to retractor arms that are hinged, which minimizes workplace interference and improves the ergonomic experience for the surgeon.
"This product, similar to others in our cardiac surgery portfolio, provides physicians additional options to perform high-quality, minimally invasive procedures on patients," said Christian Keller, president and chief executive officer of MAQUET Cardiovascular. "Our technical advancements in minimally invasive cardiac surgery continue to offer solutions to physicians that may improve patient recovery and enhance quality of life."
MAQUET, a trusted partner for hospitals and physicians for over 175 years, is the global leader in providing medical systems that meet the needs of the most medically challenging patients, while exceeding the expectations of the hospital teams that care for them. MAQUET designs, develops and distributes innovative therapy solutions and infrastructure capabilities for high-acuity areas within the hospital including the operating room (OR), hybrid OR/cath lab and intensive care unit (ICU) as well as intra and inter hospital patient transport.
Headquartered in Rastatt, Germany, MAQUET is the largest subsidiary of the publicly listed Getinge Group AB of Sweden. MAQUET generated nearly 1.4 billion Euros in 2011, representing more than half of the Getinge Group's annual revenue of 2.4 billion Euros. MAQUET has 6,000 employees in 50 international sales and service organizations, as well as a network of more than 280 sales representatives. For more information please visit www.maquet.com.
MAQUET The Gold Standard
SOURCE MAQUET Medical Systems USA